295 related articles for article (PubMed ID: 37341833)
21. Nanopolyphenol rejuvenates microglial surveillance of multiple misfolded proteins through metabolic reprogramming.
Wang D; Gu X; Ma X; Chen J; Zhang Q; Yu Z; Li J; Hu M; Tan X; Tang Y; Xu J; Xu M; Song Q; Song H; Jiang G; Tang Z; Gao X; Chen H
Acta Pharm Sin B; 2023 Feb; 13(2):834-851. PubMed ID: 36873190
[TBL] [Abstract][Full Text] [Related]
22. Microglia heterogeneity in health and disease.
Dadwal S; Heneka MT
FEBS Open Bio; 2024 Feb; 14(2):217-229. PubMed ID: 37945346
[TBL] [Abstract][Full Text] [Related]
23. mTOR-Mediated Immunometabolic Reprogramming Nanomodulators Enable Sensitive Switching of Energy Deprivation-Induced Microglial Polarization for Alzheimer's Disease Management.
Yang F; Zhao D; Cheng M; Liu Y; Chen Z; Chang J; Dou Y
ACS Nano; 2023 Aug; 17(16):15724-15741. PubMed ID: 37565731
[TBL] [Abstract][Full Text] [Related]
24. Near-infrared light reduces β-amyloid-stimulated microglial toxicity and enhances survival of neurons: mechanisms of light therapy for Alzheimer's disease.
Stepanov YV; Golovynska I; Zhang R; Golovynskyi S; Stepanova LI; Gorbach O; Dovbynchuk T; Garmanchuk LV; Ohulchanskyy TY; Qu J
Alzheimers Res Ther; 2022 Jun; 14(1):84. PubMed ID: 35717405
[TBL] [Abstract][Full Text] [Related]
25. A friend in need may not be a friend indeed: role of microglia in neurodegenerative diseases.
Kaushik DK; Basu A
CNS Neurol Disord Drug Targets; 2013 Sep; 12(6):726-40. PubMed ID: 24070095
[TBL] [Abstract][Full Text] [Related]
26. Microglia Mediated Neuroinflammation in Parkinson's Disease.
Isik S; Yeman Kiyak B; Akbayir R; Seyhali R; Arpaci T
Cells; 2023 Mar; 12(7):. PubMed ID: 37048085
[TBL] [Abstract][Full Text] [Related]
27. Microglial cells in neurodegenerative disorders.
Wojtera M; Sikorska B; Sobow T; Liberski PP
Folia Neuropathol; 2005; 43(4):311-21. PubMed ID: 16416395
[TBL] [Abstract][Full Text] [Related]
28. Microglia reprogram metabolic profiles for phenotype and function changes in central nervous system.
Yang S; Qin C; Hu ZW; Zhou LQ; Yu HH; Chen M; Bosco DB; Wang W; Wu LJ; Tian DS
Neurobiol Dis; 2021 May; 152():105290. PubMed ID: 33556540
[TBL] [Abstract][Full Text] [Related]
29. Changing paradigm to target microglia in neurodegenerative diseases: from anti-inflammatory strategy to active immunomodulation.
Peña-Altamira E; Prati F; Massenzio F; Virgili M; Contestabile A; Bolognesi ML; Monti B
Expert Opin Ther Targets; 2016; 20(5):627-40. PubMed ID: 26568363
[TBL] [Abstract][Full Text] [Related]
30. Microglia in Alzheimer's Disease: A Favorable Cellular Target to Ameliorate Alzheimer's Pathogenesis.
Sumsuzzman DM; Uddin MS; Kabir MT; Hasana S; Perveen A; Alanazi IS; Albadrani GM; Abdel-Daim MM; Ashraf GM
Mediators Inflamm; 2022; 2022():6052932. PubMed ID: 35693110
[TBL] [Abstract][Full Text] [Related]
31. Microglia and lipids: how metabolism controls brain innate immunity.
Chausse B; Kakimoto PA; Kann O
Semin Cell Dev Biol; 2021 Apr; 112():137-144. PubMed ID: 32807643
[TBL] [Abstract][Full Text] [Related]
32. Pharmacological Modulation of Functional Phenotypes of Microglia in Neurodegenerative Diseases.
Song GJ; Suk K
Front Aging Neurosci; 2017; 9():139. PubMed ID: 28555105
[TBL] [Abstract][Full Text] [Related]
33. Distinct microglial response against Alzheimer's amyloid and tau pathologies characterized by P2Y12 receptor.
Maeda J; Minamihisamatsu T; Shimojo M; Zhou X; Ono M; Matsuba Y; Ji B; Ishii H; Ogawa M; Akatsu H; Kaneda D; Hashizume Y; Robinson JL; Lee VM; Saito T; Saido TC; Trojanowski JQ; Zhang MR; Suhara T; Higuchi M; Sahara N
Brain Commun; 2021; 3(1):fcab011. PubMed ID: 33644757
[TBL] [Abstract][Full Text] [Related]
34. Circadian regulation of microglia function: Potential targets for treatment of Parkinson's Disease.
Kou L; Chi X; Sun Y; Yin S; Wu J; Zou W; Wang Y; Jin Z; Huang J; Xiong N; Xia Y; Wang T
Ageing Res Rev; 2024 Mar; 95():102232. PubMed ID: 38364915
[TBL] [Abstract][Full Text] [Related]
35. Immunometabolism in the Brain: How Metabolism Shapes Microglial Function.
Bernier LP; York EM; MacVicar BA
Trends Neurosci; 2020 Nov; 43(11):854-869. PubMed ID: 32958333
[TBL] [Abstract][Full Text] [Related]
36. The immunometabolic reprogramming of microglia in Alzheimer's disease.
Chen H; Guo Z; Sun Y; Dai X
Neurochem Int; 2023 Dec; 171():105614. PubMed ID: 37748710
[TBL] [Abstract][Full Text] [Related]
37. Metabolic reprogramming mediates hippocampal microglial M1 polarization in response to surgical trauma causing perioperative neurocognitive disorders.
Luo G; Wang X; Cui Y; Cao Y; Zhao Z; Zhang J
J Neuroinflammation; 2021 Nov; 18(1):267. PubMed ID: 34774071
[TBL] [Abstract][Full Text] [Related]
38. Microglia-Specific Metabolic Changes in Neurodegeneration.
Aldana BI
J Mol Biol; 2019 Apr; 431(9):1830-1842. PubMed ID: 30878483
[TBL] [Abstract][Full Text] [Related]
39. Recent progress in therapeutic strategies for microglia-mediated neuroinflammation in neuropathologies.
Gupta N; Shyamasundar S; Patnala R; Karthikeyan A; Arumugam TV; Ling EA; Dheen ST
Expert Opin Ther Targets; 2018 Sep; 22(9):765-781. PubMed ID: 30138572
[TBL] [Abstract][Full Text] [Related]
40. A Breakdown in Metabolic Reprogramming Causes Microglia Dysfunction in Alzheimer's Disease.
Baik SH; Kang S; Lee W; Choi H; Chung S; Kim JI; Mook-Jung I
Cell Metab; 2019 Sep; 30(3):493-507.e6. PubMed ID: 31257151
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
